Rule Requiring Drug Prices in TV Ads Blocked by Judge
A Trump administration rule to force pharmaceutical companies to disclose the list prices of their drugs in television ads was blocked by a federal judge.
A Trump administration rule to force pharmaceutical companies to disclose the list prices of their drugs in television ads was blocked by a federal judge.
The FDA has announced a new plan to significantly modernize the regulation and oversight of dietary supplements.
Rising drug spending in the United States is being fueled by expensive name-brand prescription medicines.
Pregnant women are considered a “vulnerable” population in the eyes of clinical researchers.
In the first six months of 2018, 8.8 percent of U.S. individuals of all ages were uninsured, which was not significantly different from 2017.
Millions of workers gained insurance coverage under the Affordable Care Act (ACA) without adverse effects on labor markets.
Ingesting nonsteroidal anti-inflammatory drugs (NSAID) at a higher potency level may cause nausea, vomiting, epigastric pain, diarrhea, tinnitus, headache, and even gastrointestinal bleeding; pediatric patients are also at greater risk of developing NSAID-associated renal injury.
The American Heart Association and others are urging the court to reconsider changes to short-term limited-duration insurance plans.
According to an article published in Headache, the US Food and Drug Administration (FDA) was aware of safety issues associated with the Zecuity transdermal patch for migraine prior to its approval.
The FDA has launched the MyStudies App, a mobile application aimed at supporting the collection of “real world” data and evidence for medical use.